Postoperative nomogram for disease-specific survival after an R0 resection for gastric carcinoma

被引:355
作者
Kattan, MW [1 ]
Karpeh, MS [1 ]
Mazumdar, M [1 ]
Brennan, MF [1 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA
关键词
D O I
10.1200/JCO.2003.01.240
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose : Few published studies have addressed individual patient risk after R0 resection for gastric cancer. We developed and internally validated a nomogram that combines these factors to predict the probability of 5-year gastric cancer-specific survival on the basis of 1,039 patients treated at a single institution. Methods: Nomogram predictor variables included age, sex, primary site (distal one-third, middle one-third, gastro-esophageal junction, and proximal one-third), Lauren histotype (diffuse, intestinal, mixed), number of positive lymph nodes resected, number of negative lymph nodes resected, and depth of invasion. Death as a result of gastric cancer was the predicted end point. The concordance index was used as an accuracy measure, with bootstrapping to correct for optimistic bias. Calibration plots were constructed. Results: Gastric cancer-specific survival at 5 years was 50%. A nomogram was constructed on the basis of a Cox regression model. The bootstrap-corrected concordance index was 0.80. When compared with the predictive ability of American Joint Committee on Cancer stage, the nomogram discrimination was superior (P < .001). Nomogram calibration appeared to be excellent. Conclusion: A nomogram was developed to predict 5-year disease-specific survival after R0 resection for gastric cancer. This tool should be useful for patient counseling, follow-up scheduling, and clinical trial eligibility determination. (C) 2003 by American Society of Clinical Oncology.
引用
收藏
页码:3647 / 3650
页数:4
相关论文
共 11 条
[1]   International validation of a preoperative nomogram for prostate cancer recurrence after radical prostatectomy [J].
Graefen, M ;
Karakiewicz, PI ;
Cagiannos, I ;
Quinn, DI ;
Henshall, SM ;
Grygiel, JJ ;
Sutherland, RL ;
Stricker, PD ;
Klein, E ;
Kupelian, P ;
Skinner, DG ;
Lieskovsky, G ;
Bochner, B ;
Huland, H ;
Hammerer, PG ;
Haese, A ;
Erbersdobler, A ;
Eastham, JA ;
de Kernion, J ;
Cangiano, T ;
Schröder, FH ;
Wildhagen, MF ;
van der Kwast, TH ;
Scardino, PT ;
Kattan, MW .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (15) :3206-3212
[2]   Validation study of the accuracy of a postoperative nomogram for recurrence after radical prostatectomy for localized prostate cancer [J].
Graefen, M ;
Karakiewicz, PI ;
Cagiannos, I ;
Klein, E ;
Kupelian, PA ;
Quinn, DI ;
Henshall, SM ;
Grygiel, JJ ;
Sutherland, RL ;
Stricker, PD ;
de Kernion, J ;
Cangiano, T ;
Schröder, FH ;
Wildhagen, MF ;
Scardino, PT ;
Kattan, MW .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (04) :951-956
[3]   EVALUATING THE YIELD OF MEDICAL TESTS [J].
HARRELL, FE ;
CALIFF, RM ;
PRYOR, DB ;
LEE, KL ;
ROSATI, RA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1982, 247 (18) :2543-2546
[4]  
Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO
[5]  
2-4
[6]  
HARRELL FE, 2001, REGRESSION MODELING
[7]  
Karpeh M. S., 2001, CANC PRINCIPLES PRAC, P1092
[8]   Gastric carcinoma [J].
Karpeh, MS ;
Brennan, MF .
ANNALS OF SURGICAL ONCOLOGY, 1998, 5 (07) :650-656
[9]   Postoperative nomogram for 12-year sarcoma-specific death [J].
Kattan, MW ;
Leung, DHY ;
Brennan, MF .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (03) :791-796
[10]   Pretreatment nomogram for predicting the outcome of three-dimensional conformal radiotherapy in prostate cancer [J].
Kattan, MW ;
Zelefsky, MJ ;
Kupelian, PA ;
Scardino, PT ;
Fuks, Z ;
Leibel, SA .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (19) :3352-3359